Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How does interferon exert its cell growth inhibitory effect?

D Grandér1, O Sangfelt, S Erickson

  • 1Department of Oncology-Pathology, Karolinska Hospital, Stockholm, Sweden. dan@deptonc.ks.se

European Journal of Haematology
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Environmentally driven immune imprinting protects against allergy.

Nature·2026
Same author

Environmentally driven immune imprinting protects against allergy.

Nature·2026
Same author

Time-Delay Cosmography: Measuring the Hubble Constant and Other Cosmological Parameters with Strong Gravitational Lensing.

Space science reviews·2024
Same author

Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death.

Science advances·2020
Same author

Chained Bell Inequality Experiment with High-Efficiency Measurements.

Physical review letters·2017
Same author

PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma.

Leukemia·2017
Same journal

The Effect of Polycythemia Vera on Pregnancy Complications. The Analysis of an American Population Database With Over 9 Million Deliveries.

European journal of haematology·2026
Same journal

Efficacy, Safety, and Treatment-Delivery Feasibility of Autologous Gene Therapy for Sickle Cell Disease: A Systematic Review With Descriptive Synthesis of Clinical Trials.

European journal of haematology·2026
Same journal

ARHGEF2::JAK2 Fusion Drives Leukemogenesis via CCNB1-Dependent Signaling.

European journal of haematology·2026
Same journal

Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management.

European journal of haematology·2026
Same journal

Multiple Myeloma and the Illusion of the Evidence Pyramid.

European journal of haematology·2026
Same journal

Outsmarting Antigen Escape: Next-Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies.

European journal of haematology·2026
See all related articles

Interferons (IFNs) are used to treat cancers, but how they work is unclear. This review explores how IFNs reduce cell numbers, their molecular basis, and clinical relevance in cancer therapy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Interferons (IFNs) are established therapies for various hematological and non-hematological malignancies.
  • The precise mechanisms underlying the anti-tumor effects of IFNs remain incompletely understood.
  • IFNs modulate diverse cellular responses, with cell growth inhibition being a key proposed mechanism.

Purpose of the Study:

  • To review the cellular events contributing to reduced cell counts after IFN treatment.
  • To elucidate the molecular mechanisms responsible for IFN-induced cell reduction.
  • To discuss the clinical significance of these cellular effects in cancer therapy.

Main Methods:

  • Literature review of studies on Interferon (IFN) therapy in malignancies.

Related Experiment Videos

  • Analysis of cellular and molecular mechanisms of IFN action.
  • Evaluation of clinical data regarding IFN efficacy and side effects.

    • Main Results:

    • IFNs induce a decrease in cell proliferation and promote apoptosis in cancer cells.
    • Key molecular pathways modulated by IFNs include JAK/STAT signaling, cell cycle regulation, and immune cell activation.
    • Cellular growth inhibition is a significant contributor to the overall anti-tumor effect of IFNs.

    Conclusions:

    • Understanding IFN-mediated cellular events and molecular mechanisms is crucial for optimizing cancer treatment strategies.
    • The cell growth inhibitory effects of IFNs are clinically relevant and contribute to their therapeutic efficacy in various cancers.
    • Further research into IFN mechanisms can lead to improved therapeutic applications and combination therapies.